CALL FOR PAPERS Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function

Thomas E. Sussan, Sachin Gajghate, Samit Chatterjee, Pooja Mandke, Sarah McCormick, Kuladeep Sudini, Sarvesh Kumar, Patrick N. Breysse, Gregory B. Diette, Venkataramana K. Sidhaye, and Shyam Biswal Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; and Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland

[1]  H. Zhang,et al.  NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation. , 2014, The Journal of clinical investigation.

[2]  N. Vaziri,et al.  The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease☆ , 2013, Redox biology.

[3]  J. Greenberg,et al.  Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[4]  Ning Li,et al.  Nrf2 Deficiency in Dendritic Cells Enhances the Adjuvant Effect of Ambient Ultrafine Particles on Allergic Sensitization , 2013, Journal of Innate Immunity.

[5]  L. Akinbami,et al.  National surveillance of asthma: United States, 2001-2010. , 2012, Vital & health statistics. Series 3, Analytical and epidemiological studies.

[6]  L. Akinbami,et al.  Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. , 2012, NCHS data brief.

[7]  C. Brightling,et al.  Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma. , 2012, American journal of respiratory and critical care medicine.

[8]  S. Reddy,et al.  Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. , 2011, American journal of respiratory and critical care medicine.

[9]  K. Chung,et al.  Transforming growth factor-β and nuclear factor E2–related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma. , 2011, American journal of respiratory and critical care medicine.

[10]  P. Howarth,et al.  Defective epithelial barrier function in asthma. , 2011, The Journal of allergy and clinical immunology.

[11]  S. Holgate,et al.  The sentinel role of the airway epithelium in asthma pathogenesis , 2011, Immunological reviews.

[12]  Hailong Wu,et al.  Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells. , 2011, Journal of medicinal chemistry.

[13]  L. Yarmus,et al.  Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model , 2011, Science Translational Medicine.

[14]  S. Ryter,et al.  Isolation of mouse respiratory epithelial cells and exposure to experimental cigarette smoke at air liquid interface. , 2011, Journal of visualized experiments : JoVE.

[15]  S. Biswal,et al.  Nuclear erythroid 2 p45-related factor 2 inhibits the maturation of murine dendritic cells by ragweed extract. , 2010, American journal of respiratory cell and molecular biology.

[16]  David J. Arenillas,et al.  Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis , 2010, Nucleic acids research.

[17]  T. Mariani,et al.  Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. , 2010, American journal of respiratory cell and molecular biology.

[18]  N. Kikuchi,et al.  Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance , 2010, Respiratory research.

[19]  E. Walters,et al.  Increased vascular permeability precedes cellular inflammation as asthma control deteriorates , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  M. Sporn,et al.  The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice. , 2009, American journal of respiratory and critical care medicine.

[21]  D. Davies,et al.  Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches. , 2009, The Journal of allergy and clinical immunology.

[22]  Masayuki Yamamoto,et al.  Disruption of Nrf2 Impairs the Resolution of Hyperoxia-Induced Acute Lung Injury and Inflammation in Mice1 , 2009, The Journal of Immunology.

[23]  S. Biswal,et al.  Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[24]  F. Polack,et al.  Antiviral Activity of Nrf2 in a Murine Model of Respiratory Syncytial Virus Disease at a Glance Commentary , 2022 .

[25]  M. Sporn,et al.  Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice , 2009, Proceedings of the National Academy of Sciences.

[26]  S. Biswal,et al.  Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice , 2008, PloS one.

[27]  S. Biswal,et al.  Disruption of the Transcription Factor Nrf2 Promotes Pro-Oxidative Dendritic Cells That Stimulate Th2-Like Immunoresponsiveness upon Activation by Ambient Particulate Matter1 , 2008, The Journal of Immunology.

[28]  O. Kalayci,et al.  A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. , 2008, The Journal of allergy and clinical immunology.

[29]  B. Crestani,et al.  Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema , 2008, Thorax.

[30]  H. Hoogsteden,et al.  Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. , 2008, Canadian journal of physiology and pharmacology.

[31]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[32]  M. Sporn,et al.  Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. , 2006, Biochemical and biophysical research communications.

[33]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[34]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[35]  C. Akdis,et al.  Apoptosis and Loss of Adhesion of Bronchial Epithelial Cells in Asthma , 2005, International Archives of Allergy and Immunology.

[36]  W. Mitzner,et al.  Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice , 2005, The Journal of experimental medicine.

[37]  S. Holgate,et al.  Epithelial stress and structural remodelling in childhood asthma , 2005, Thorax.

[38]  Irina Petrache,et al.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. , 2004, The Journal of clinical investigation.

[39]  S. Reddy,et al.  The transcription factor NRF2 protects against pulmonary fibrosis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  M. Kwak,et al.  Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway , 2003, Molecular and Cellular Biology.

[41]  Yuichi Sugiyama,et al.  Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. , 2003, Biochemical and biophysical research communications.

[42]  B. Ma,et al.  New insights into the pathogenesis of asthma. , 2003, The Journal of clinical investigation.

[43]  R. Rao,et al.  Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. , 2002, The Biochemical journal.

[44]  S. Biswal,et al.  Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. , 2002, Cancer research.

[45]  J. Renauld.  New insights into the role of cytokines in asthma , 2001, Journal of clinical pathology.

[46]  R. Dweik,et al.  Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response , 2000, The Lancet.

[47]  T. Sandström,et al.  Altered lung antioxidant status in patients with mild asthma , 1999, The Lancet.

[48]  T. Kensler,et al.  Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention. , 1998, Carcinogenesis.

[49]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[50]  J. Zweier,et al.  Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones. , 1996, Carcinogenesis.

[51]  A. Choi,et al.  Parallel Induction of Heme Oxygenase-1 and Chemoprotective Phase 2 Enzymes by Electrophiles and Antioxidants: Regulation by Upstream Antioxidant-Responsive Elements (ARE) , 1995, Molecular medicine.

[52]  V. Besnard,et al.  Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. , 2013, Antioxidants & redox signaling.

[53]  Y. Nasuhara,et al.  Downregulated Nf-e2-related Factor 2 in Pulmonary Macrophages of Aged Smokers and Copd Patients , 2022 .

[54]  Soumyaroop Bhattacharya,et al.  Epithelial cell PPAR[gamma] contributes to normal lung maturation. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  J. Hayes,et al.  Glutathione transferases. , 2005, Annual review of pharmacology and toxicology.

[56]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[57]  M. Wills-Karp.  Immunologic basis of antigen-induced airway hyperresponsiveness. , 1999, Annual review of immunology.

[58]  R. Mulcahy,et al.  Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. , 1999, Biochemical and biophysical research communications.